Related Experiment Video
Updated: Jan 28, 2026

A Protocol for Constructing a Rat Wound Model of Type 1 Diabetes
Published on: February 17, 2023
Epigenetic Modifications and Their Role in Type 1 Diabetes Development: A Review
Jenner Chrystian Veríssimo de Azevedo1, Fernando Liberalino Fernandes2, Tayline Dantas Rodrigues2
1Department of Pediatrics, Federal University of Rio Grande do Norte, 59078-970, Natal, Brazil.
Epigenetic modifications like DNA methylation and noncoding RNAs are key in Type 1 Diabetes (T1DM) development. Understanding these epigenetic changes offers new avenues for T1DM biomarkers and therapies.
Area of Science:
- Immunology
- Endocrinology
- Genetics
Background:
- Type 1 Diabetes Mellitus (T1DM) is an autoimmune disease characterized by pancreatic beta-cell destruction and insulin deficiency.
- Its development is influenced by genetic susceptibility, environmental factors, and epigenetic modifications.
- Epigenetic mechanisms are increasingly recognized as crucial players in T1DM pathogenesis.
Purpose of the Study:
- To review the role of epigenetic mechanisms in Type 1 Diabetes Mellitus.
- To explore the potential of epigenetic modifications as biomarkers for T1DM.
- To identify epigenetic targets for novel T1DM therapeutic interventions.
Main Methods:
- A comprehensive literature review was performed using major scientific databases (PubMed, Scopus, Web of Knowledge, Google Scholar).
- Studies investigating DNA methylation, histone modifications, and noncoding RNAs in T1DM patients and models were analyzed.
- Mechanisms linking epigenetic alterations to T1DM progression were systematically identified.
Main Results:
- Epigenetic alterations, including aberrant DNA methylation, histone modifications, and dysregulated non-coding RNAs, are central to immune dysregulation and beta-cell dysfunction in T1DM.
- DNA methylation impacts genes critical for immune response, insulin production, and beta-cell survival.
- Non-coding RNAs modulate inflammatory and transcriptional pathways, while histone modifications affect chromatin accessibility, exacerbating beta-cell loss.
Conclusions:
- Epigenetic mechanisms integrate genetic predispositions with environmental triggers, influencing T1DM autoimmunity and disease variability.
- These epigenetic changes are vital for disease onset and progression, highlighting their significance for early detection.
- Targeting epigenetic pathways offers promising strategies for developing predictive biomarkers and innovative therapies to restore immune tolerance and beta-cell function in T1DM.
Related Concept Videos
Epigenetic Regulation
Epigenetic Regulation
X-chromosome...
Diabetes Mellitus: Type 2 and Gestational
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Piaget's Stage 1 of Cognitive Development
Exploration...
Review and Preview
Percentiles are a type of fractile that partition data into...

